Found: 4
Select item for more details and to access through your institution.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD‐1 blockade.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1655
- By:
- Publication type:
- Article
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32272-6
- By:
- Publication type:
- Article
The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5007, doi. 10.3390/cancers14205007
- By:
- Publication type:
- Article
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2040, doi. 10.3390/cancers13092040
- By:
- Publication type:
- Article